Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cytochroma discovers new retinoic acid metabolizing cytochrome P450

Aug. 26, 2003

Good toxicity profile reported for squalamine in patients with solid tumors

Aug. 26, 2003

Local methotrexate reported to inhibit tumor progression in mice

Aug. 26, 2003

New alphavbeta3/alphavbeta5 antagonists prepared and tested at Bayer

Aug. 25, 2003

Thalidomide recommended for approval in Australia

Aug. 25, 2003

Phase I bridging study of LEP-ETU commences

Aug. 25, 2003

IND filed for Atrigel formulation of octreotide

Aug. 25, 2003

Antitumor effects described for SU-11654 in spontaneous canine tumors

Aug. 25, 2003

Eisai claims novel proteasome inhibitors with utility as antitumor agents

Aug. 22, 2003

Substance P-derived peptides with NK1-antagonist activity and their use as antitumor agents

Aug. 22, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...